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Adherence is still an important issue considering new advances in Obstructive Sleep
Apnea (OSA) treatment, as automatic positive airway pressure (APAP). The aim of
the present study was to identify and explore relationships between identiﬁed predic-
tors of adherence, over time. After overnight sleep study and OSA diagnosis and
during a six-month APAP treatment period, a total of 153 patients underwent a three
time psychological protocol evaluation. Generalized estimating equations were
applied to analyzed repeated measurements in the same individuals. Results show
that 40% of patients were poorly adherent and 60% were adherent after six months
of treatment. The results conﬁrmed a predictive value of age, self-efﬁcacy, decisional
balance index and health-related quality of life (HRQoL) in APAP adherence. Fur-
thermore, the results revealed an interaction between time and illness cognitive rep-
resentations, and self-efﬁcacy and family coping, in explaining adherence patterns
over time. Therefore, understanding the causality of theoretically derived constructs
is crucial to predict the continuity of APAP adherence.
Keywords: APAP treatment; adherence; illness cognitive representations; self-efﬁcacy
outcome expectations; family coping
Introduction
Adherence is established as one of the most common problems facing chronic diseases
management. During ﬁve decades of research, concerted efforts have been made to
understand adherence difﬁculties and identify predictors of non-adherence (Dunbar-
Jacob & Mortimer-Stephens, 2001). Since its introduction, in 1981, by Sullivan, contin-
uous positive airway pressure (CPAP) has become the widely accepted treatment of
choice for patients with Obstructive Sleep Apnea (OSA), which requires consistent
adherence. The recent alternative automatic positive airway pressure (APAP) device has
prompted several studies to compare its effectiveness with CPAP (Galetke, Anduleit,
Richter, Stieglitz, & Randerath, 2008; Mulgrew, Cheema, Fleetham, Ryan, & Ayas,
2007). As an example, our group recently showed the effectiveness of APAP therapy in
controlling the majority of OSA symptoms beyond sleepiness and snoring (Cruz,
Drummond, & Winck, 2012). But, as in general, adherence results are mixed and the
effect of APAP on enhancing adherence remains unclear (Haniffa, Lasserson, & Smith,
2004). Although arbitrary, the used cut-off for no-adherence is based on minimal criteria
for adequate sleep, this is less than 4 h for 70% of the treatment period (Collen, Lettieri,
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Kelly, & Roop, 2009; Engleman, Martin, & Douglas, 1994; Stepnowsky & Dimsdale,
2002).
Current relentless pursuit of predictors of adherence to CPAP has revealed mixed
results in socio-demographic and clinical variables. Older age (Budhiraja et al., 2007;
Woehrle, Graml, & Weinreich, 2011) and being male (Joo & Herdegen, 2007) are often
related to adherence, although at odds (Lewis, Seale, Bartle, Watkins, & Ebden, 2004).
Even though the marital status does not predict adherence (Sucena, Liistro, Aubert,
Rodenstein, & Pieters, 2006), it seems to justify signiﬁcant differences in a way of bet-
ter adherence (Cartwright, 2008). An elevated basal (Apnoea Hypopnoea Index) AHI
predicts adherence, at one and three months and CPAP treatment (Hui et al., 2001).
Likewise, these results are not consistent (Gay, Weaver, Loube, & Iber, 2006). These
predictions failed to account for more than 10% of the variance in adherence (Collard,
Pieters, Aubert, Delguste, & Rodenstein, 1997). Despite the technological advances of
CPAP equipment, their effect on adherence has not been steadily proved (Weaver &
Grunstein, 2008).
Regarding the multiplicity of psychological variables that have been studied (beliefs,
self-efﬁcacy, outcome expectations, social support, decisional balance, process of
change and coping) the studies are unanimous in identifying these as main predictors of
adherence, mostly based on theory-driven constructs (Aloia, Arnedt, Stanchina, &
Millman, 2007; Olsen, Smith, Oei, & Douglas, 2008; Stepnowsky, Bardwell, Moore,
Ancoli-Israel, & Dimsdale, 2002; Stepnowsky & Dimsdale, 2002; Stepnowsky, Marler,
Palau, & Annette Brooks, 2006; Tyrrell, Poulet, Pe Pin, & Veale, 2006; Wild, Engl-
eman, Douglas, & Espie, 2004). Current approaches used to evaluate behavioral change
are Bandura’s Social cognitive theory (Bandura, 1997) (describing an agreement about
the essential determinants of which health effective practices promote health) and
Porchaska and DiClementes’s Transtheoretical model (Prochaska, Redding, Harlow,
Rossi, & Velicer, 1994) (that focus the need for movement through discrete motiva-
tional stages over time and recognizing that individuals differ in their readiness for
change) The advantage of psychological constructs is their potential targets for treat-
ment that become enlarged (Aloia, Arnedt, Stepnowsky, Hecht, & Borrelli, 2005). Psy-
chological constructs are considered dynamic variables and self-efﬁcacy has been
pointed as a main predictor to implement efforts to persist in behavioral, when CPAP is
already in use (Aloia et al., 2001). So, understanding how perceptions, experience and
impact of having OSA might inﬂuence a patient’s interpretation and response is still
missing. Therefore Self-Regulatory Leventhal’s model proposed an adaptive system, in
which representation of illness experience (active parallel cognitive and emotional
processing) might guide coping responses, followed by the appraisal of success/failure
of those strategies (Leventhal, Leventhal, & Cameron, 2001).
When facing a new diagnosis such as OSA and its treatment, family members are
crucial. In fact, bed patterns are considered key promoters for the patient to seek help
(McArdle, Kingshott, Engleman, Mackay, & Douglas, 2001), as minimally symptomatic
or asymptomatic OSA is estimated to occur in each of ﬁve subjects and often not rec-
ognized (Young, Peppard, & Gottlieb, 2002). Although, the effect of family support and
encouragement has not been tested in OSA, it makes intuitive sense important for
adherence to APAP (Shapiro & Shapiro, 2010). Thus, information regarding family cop-
ing, deﬁned by a family’s ability to cope with demands, family resources, and meanings
associated with disease and subsequent implications (Montagnino & Mauricio, 2004)
could provide new information about what predicts adherence to APAP in a long term
period. health-related quality of life (HRQoL) may function as a main outcome variable


























that embraces subjective patient’s evaluation of impairment caused by treatment and the
disease process impact (Gay et al., 2006; Joo & Herdegen, 2007). Relationships
between theoretically driven constructs related to adherence could therefore increase
knowledge to design interventions to increase adherence to APAP.
Research, in the last decades, has explored several theory driven constructs to
explain CPAP adherence, and although some identiﬁed variables play an important role,
the relationship between these variables and over time remains unclear. According to
previous studies, one pathway that needs to be more explored is the relationship among
predictors of health behavior such as self-efﬁcacy, outcome expectancies, illness and
treatment perception and coping.
The present study has therefore focused on identifying the predictors of adherence
to APAP treatment, during a six-month period, based on constructs derived from theo-
retical models focused on health-related behaviors. Also to address causality of its rela-
tionships was pointed as a main limitation by Aloia et al. (2005).
Methods
Participants
This is a prospective cohort study, with three assessments (baseline, T1, 1–2months,
T2 and 3–6months, T3) conducted in a Sleep Disordered Breathing Clinic of a Univer-
sity Hospital in Northern Portugal. Between January 2009 and 2011, 153 consecutive
OSA patients with APAP treatment indication underwent a standardized protocol (gen-
eral clinic evaluation by sleep specialist, home sleep study, and psychological evalua-
tion, including psychological morbidity, illness perceptions, self-efﬁcacy, outcome
expectations, social support, decision balance, change processes, family coping and
quality of life). Exclusion criteria included the presence of psychiatric disorders or
other sleep disorders. The study was approved by the hospital’s research ethics com-
mittee and participants answered the written informed consent. Sixty-one patients were
classiﬁed as poor adherent and 92 were classiﬁed as adherent at times two and three
(Table 1).
Disease assessment – home sleep study
An overnight sleep study using a ﬁve-channel recording device (Sleep Screen, ViasysTM
Healthcare) was used, as previously described (Sampaio, Pereira, & Winck, 2012),
allowing objective measurement of APAP adherence. APAP was set with a minimum
pressure of 4 cm H2O and a maximum pressure of 15 cm H2O, by an experienced sleep
physician.
Table 1. Cross-tabs descriptive analyses of adherence patterns in T2 and T3 (n = 153).
Time 2
Poor adherents Adherents Total
Time 3 Poor adherents 50(82%) 11(12%) 61
Adherents 11(18%) 81(88%) 92
Total 61 92 153



























Initially a pilot study was conducted with all instruments and design procedures in 10
patients of the same hospital, with similar socio-demographic and clinical characteristics
of the present sample. Upon CPAP prescription (T1), the following baseline question-
naires were administered, in face to face interview by a trained health psychologist and
repeated in T2 and T3.
(1) Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983).
HADS, is a 14-item scale with two subscales, measuring anxiety and depression, in a
four point (0–3) Likert scale. Scores range from 0 to 21, in both scales. A score above
11 (cut-off threshold) indicates a clinical diagnosis of anxiety and depression. In the
current sample, internal consistency reliability coefﬁcient (Cronbach, 1951) was
adequate for both anxiety (α= .72) and depression subscales (α = .82), indicating good
reliability.
(2) Determinants of nasal CPAP compliance (Stepnowsky, Marler, & Ancoli-Israel,
2002). This instrument is based on two theories and has six scales: self-efﬁcacy (four
items), outcome expectations (four items), knowledge (11 items) and social support
(nine items) based on socio cognitive theory (Bandura, 1997) and-decisional balance
index (12 items) and process of change (20 items) based on a transtheoretical model
(Prochaska et al., 1994). All scales require a (1–5) Likert response and higher scores
indicate higher behavior engagement towards CPAP compliance. In the current sample,
internal consistency reliability coefﬁcient (Cronbach, 1951) was adequate for the fol-
lowing scales – self-efﬁcacy (α= .87), outcome expectations (α = .75), social support
(α= .94), decisional balance index (α= .86) and process of change (α = .88), indicating
good reliability. Due to the fact that Cronbach alpha for the Knowledge scale (α = .53)
was low it was not included in the hypothesis testing. The process of change subscale
was completed only in T2 and T3 assessment moments, after CPAP’s use.
(3) Illness Perception Questionnaire-Brief (Broadbent, Petrie, Main, & Weinman,
2006). This instrument (Figueiras et al., 2010) has eight items, combined in three
scales, that assesses illness perceptions: cognitive illness representations (consequences,
timeline, personal control, treatment control, and identity); emotional representations
(concern and emotions); and illness comprehensibility. All these items are rated in a
ten-point Likert scale. This instrument also has another item, causal representation,
which is answered in an open-ended response. High scores (sum of all items) indicated
a more threatening perception of illness. In the current sample, internal consistency was
between .60 and .72.
(4) SAQLI Sleep Apnea Quality of Life Index (Sampaio et al., 2012) evaluates four
domains of quality of life (daily functioning; social interactions; emotional functioning;
symptoms) critical to this population and an additional domain (treatment related symp-
toms) evaluates treatment effect (used in T2 and T3). Scores are calculated as previ-
ously described (Sampaio et al., 2012) and higher scores indicated better quality of life.
SAQLI presents a high internal consistency as reﬂected by Cronbach alpha coefﬁcients
from .84 to .89 (Sampaio et al., 2012). Pearson correlation coefﬁcients between SAQLI
interdomains before and after CPAP treatment and clinical variables were highly corre-
lated (Sampaio et al., 2012).
(5) Family Crisis Oriented Evaluation Scales (F-Copes) (McCubbin, Larsen, &
Olson, 1982) measure how families respond/cope with problematic or difﬁcult situa-
tions. Portuguese version includes ﬁve subscales: acquiring social support (six items);
reframing (seven items); seeking spiritual support (three items); mobilizing the family to


























acquire and accept help (eight items); and passive appraisal (six items). Cronbach
alpha for the total scale was .83. Responses were scored using a ﬁve-point likert scale
(one, lower use of coping strategy and ﬁve, higher use of coping strategy). Higher
scores indicate higher family coping strategies.
Data analyses
Descriptive analyses of socio-demographic variables (age, gender and marital status),
clinical variables (AHI, mask leakage, P95cm percentile pressure-P95 which is the level
of APAP pressure exceeded only 5% of the time, P95), and psychosocial variables (anx-
iety, depression, self-efﬁcacy, outcome expectations, social support, decisional balance
index, process of change, illness representations and family coping) were performed.
Categorical variables were described as absolute frequencies and relative frequencies;
mean and standard deviation were used for continuous variables.
The selected cut-off point for adherence was based on: the average number of hours
used and the total usage percentage. So poorly adherent patients were those who used
APAP< 4 h/night and <70% total days of usage and adherent patients were those who
used APAP > 4 h/night and >70% total days of usage (Collen et al., 2009; Engleman
et al., 1994; Stepnowsky & Dimsdale, 2002).
To evaluate treatment adherence groups, multivariate models of generalized estimat-
ing equations (GEE) were used. GEE is a method to analyze longitudinal or repeated
measures, taking into account that measurements of the same individual over time are
correlated (Fitzmaurice, Laird, & Ware, 2004). The advantage of this method is to pro-
vide consistent estimates of parameters associated with covariates in the model. A
robust variance estimator was used to compute standard errors. Following the recom-
mendations of Pepe & Anderson (1994), we assume an exchangeable correlation matrix
in the estimation of parameters of the models.
Results
Of the total 153 OSA patients, 61 (40%) were poorly adherent and 92 (60%) were
adherent, at six months of APAP treatment. Poorly adherent patients used APAP on
average 3:12 h (SD= 1:39 h) and 3:59 (SD= 1:50 h) and 28 and 37% of days in Time 2
and 3, respectively. Adherent patients used APAP, on average, 6:28 h (SD= 0:59 h) and
6.18 h (SD= 1:15 h) and 89 and 87% of days, in Time 2 and 3, respectively. The
descriptive group analyses are presented in Table 1 at T2 and T3 of APAP adherence.
A multivariate model of GEE is presented in Table 3. Of the total variables pooled
in the analysis, those who presented a signiﬁcant univariate odds ratio like gender were
included in the GEE models analysis as well as family coping because of its relation to
CPAP adherence, in general. The descriptive statistics presented in Table 2 allowed for
comprehensive results. Other psychological and clinical variables and its interactions
were included in estimation models (processes of change, social support, illness emo-
tional representation, anxiety, depression, mask leakage, AHI and P95). Notwithstand-
ing, none of these variables revealed a signiﬁcant interaction with regard to adherence
pattern.
When adjusting for variables presented, it resulted in a model that includes age,
HRQoL, self-efﬁcacy, family coping and its interaction, decisional balance index and
interaction between illness cognitive representations and time, that explained the adher-
ence pattern over six months of treatment.


























Among the socio-demographic variables, only age increased the probability of being
adherent in 1.044 (p= .017; OR: 1.042; IC95%: 1.008–1.081). Gender is not a signiﬁ-
cant variable in this model, but from T2 to T3, female adherent percentage decreases
and male adherence increased.
A unit increase in HRQoL was signiﬁcantly related to adherence (p= .006; OR:
1.489; IC95%: 1.122–1.977). In the ﬁrst models tested, family coping was not associ-
ated with adherence (p= .935; OR: 1.002; IC95%: .977–1.021), although self-efﬁcacy
increased its probability (p< .001; OR: 2.047; IC95%: 1.430–2.929). Interestingly, when
these two variables were associated, odds of being adherent increased by 17 units
(p< .001; OR: 17.443; IC95%: 4.573–66.52). In the same way, family coping became
signiﬁcantly associated with adherence (p= .001; OR: 1.107; IC95%: 1.045–1.173).
With a 5% error probability, this result showed a signiﬁcant interaction between
Table 2. Socio-demographic, clinical, and psychological characteristics of poor adherents and
adherents in T1–T3 (n= 153).
Time 1
Time 2 Time 3










Gender n(%) n(%) n(%) n(%) n(%)
Female 28(18.3) 10(6.54) 18(11.76) 12(7.84) 16(10.46)
Male 125(81.7) 51(33.33) 74(48.37) 49(32.03) 76(49.67)
M(SD) M(SD) M(SD) M(SD) M(SD)
Age 52.2(10.3) 50.9(10.79) 53.1(9.86) 49.5(9.68) 54.1(10.28)
Clinical variables
AHI 43.0(19.0) 4.7(3.79) 4.7(5.21) 4.5(4.38) 4.3(5.33)
Mean leak
(L/min)
– 26.9(14.56) 29.6(17.01) 24.8(17.41) 27.6(14.17)
P95
(cm H2O)
– 10.7(2.79) 11.40(2.83) 10.6(2.98) 11.3(2.96)
Determinates of nasal APAP
Self-efﬁcacy 4.5(1.17) 3.8(.99) 4.8(.47) 3.9(1.2) 4.7(.48)
Outcome
expectations
4.3(.77) 4.2(1.02) 4.6(.57) 4.2(.95) 4.7(.61)
Social
support




4.0(.57) 3.6(.85) 4.3(.60) 3.6(.87) 4.4(.06)
Processes of
change
– 2.6(.97) 2.7(.76) 2.5(.85) 2.6(.67)
Psychological
variables
Anxiety 8.3(4.61) 7.6(5.15) 5.76(4.79) 7.3(5.37) 5.1(4.38)
Depression 5.7(3.66) 4.8(4.13) 3.8(3.47) 4.4(4.43) 3.4(3.6)
Illness
cognitive R.
23.0(8.37) 19.9(8.91) 17.8(8.19) 20.0(9.15) 14.5(7.68)
Illness
emotional R.
13.5(5.85) 10.7(6.52) 9.7(6.01) 9.0(6.35) 6.7(6.21)
Family coping 97.5(16.47) 90.5(17.02) 93.6(15.99) 89.6(17.7) 93.3(16.68)
HRQoL 4.5(1.28) 4.9(1.35) 5.7(.96) 5.4(1.18) 6.0(.77)
Notes: M – Mean; SD – Standard Deviation; AHI – Apnoea Hypopnoea Index; HRQL – Health-Related
Quality of Life.


























self-efﬁcacy and family coping (p= .001; OR: .978; IC95%: .966–.991). So, when con-
sidering an increased self-efﬁcacy and family coping, there is a slight probability of
adherence increase. An increased unit in decisional balance index was also associated
with adherence to APAP (p= .024; OR: 1.050; IC95%: 1.006–1.095).
Time had an effect on illness cognitive representations (p = .033; OR: .951; IC95%:
.908–.996), presented in Figure 1. Association between time and threatening cognitive
Figure 1. Time effect on illness cognitive representations.
Table 3. GEE model for the adherence groups.
Adherence groups⁄
OR(1) CI95% P OR(2) CI95%
Gender
Female⁄⁄ .971 .473 1.991 .408 1.478 .586 3.726
Male 1.000 – – – 1.000 – –
Age1 .968 .939 .997 .017 1.044 1.008 1.081
HRQoL1 – T1 0983 0752 1286 .549 1.076 .774 1.618
HRQoL 0649 0520 0810 .006 1.489 1.122 1.977
Time 1159 0878 1531 – – – –
Self-efﬁcacy1 – T1 1155 0930 1434 .073 .804 .632 1.021
Self-efﬁcacy 0334 0238 0468 .000 17.443 4.573 66.53
Time 1073 0805 1432 – – – –
Family coping1 – T1 0999 0980 1018 .950 .999 0977 1022
Family coping 0996 0981 1010 .001 1.107 1.045 1.173
Time 0998 0776 1282 – – – –
Self-efﬁcacy⁄ family coping – – – .001 .978 .966 .991
Illness cognitive R1 – T1 1020 0983 1058 .857 .995 .940 1.053
Illness cognitive R 0960 0904 1020 .008 1.115 1.029 1.209
Time 0520 0282 0956 – – – –
Illness cognitive R⁄ Time 1039 1005 1073 .033 .951 .908 .996
Decisional balance index1 – T1 1008 0958 1060 .995 1.000 .945 1.059
Decisional Balance index 0907 0877 0939 .024 1.050 1.006 1.095
Time 1043 0787 1382 – – – –
Time study .055 2.107 .983 4.516
Reference category: poor adherents;
⁄⁄Females as reference category; OR(1) – Odds Ratio Univariate; OR(2) – Odds Ratio adjusted to all the
variables in the model; CI95% – Conﬁdence interval; p< .001; p< .05.
1Continuous variable.


























representations increased the probability of being poorly adherent, i.e. the adherent
group perceived OSA as a less threatening disease (cognitive representations) over time.
Discussion
Results showed a high percentage of patients to be poorly adherent, even using APAP
treatment, and a consistent pattern of adherence over time, according to the literature
(Budhiraja et al., 2007; Weaver & Sawyer, 2010). Like in previous studies referred
(Aloia et al., 2007; Olsen et al., 2008; Stepnowsky, Bardwell, Moore, Ancoli-Israel, &
Dimsdale, 2002; Stepnowsky & Dimsdale, 2002; Stepnowsky et al., 2006; Tyrrell et al.,
2006; Wild et al., 2004), theoretically derived constructs only assumed a predicted
value during treatment experience. Moreover, the nature of the relationship between
behavior change and adherence increased with continued use of the treatment (Aloia
et al., 2005). In fact, the literature is unanimous emphasizing the importance of includ-
ing other psychological theoretical constructs, that might be useful in providing evi-
dence for intervening in modiﬁable factors on APAP adherence (Aloia et al., 2005).
Therefore, in the present study two important, and not yet described, theoretically
derived constructs emerged as adherence predictors – illness cognitive representation
and family coping. Illness cognitive representation is the only predictor of adherence
that is dependent over time, i.e. as time passes, poor adherents perceive OSA and APAP
treatment as slightly threatening. Conversely, in the adherent group, cognitive illness
representations regarding OSA as a threatening illness decrease over time. This result is
in accordance with the concept of self-regulation as a dynamic process, particularly in
chronic diseases (Furze, Roebuck, Bull, Lewin, & Thompson, 2002). This result that
opens a window of intervention in the consistent early established adherence pattern
may guide future interventions in order to reverse previous established consistence of
adherence patterns.
Family coping, to our knowledge, has not been studied in OSA patients in need of
APAP, a treatment also conspicuous for those who share the same living space. In one of
the studies, previously presented (Stepnowsky et al., 2002), only active coping explained
16% of the variance in CPAP compliance in a set of measured variables. The present
study emphasized the predictive role of family coping, regarding OSA and its treatment,
when associated with self-efﬁcacy. Self-efﬁcacy has been known to be an important pre-
dictor of adherence (Aloia et al., 2007; Olsen et al., 2008; Stepnowsky, Bardwell, Moore,
Ancoli-Israel, & Dimsdale, 2002), but clearly, in our sample, higher family coping strate-
gies seem to reinforce the way that the patients perceive themselves to be capable to
respond to APAP treatment, in a wholeness interrelation. Another important psychologi-
cal construct emerged, the decisional balance index, where the pros to continue to adhere
to APAP treatment reinforce its usage. At least, as expected and widely documented, the
key clinical factor pointed about the cost-effectiveness of treatment of OSA is HRQoL
improvement (Mar, Rueda, Duran-Cantolla, Schechter, & Chilcott, 2003), which may
reinforce continuing APAP usage and indeed predict adherence. Our study also rein-
forces previous results of older age as a predictor of adherence (Budhiraja et al., 2007).
Although gender did not predict adherence, our results are consistent with other studies
(Joo & Herdegen, 2007), and there is a slight decrease in APAP usage by women, over
time, contrary to male patients.
Several limitations in the present study need to be acknowledged. The ﬁrst concerns
the generalizations of results due to the single country nature of this study. Like other
longitudinal studies, 25% of patients were lost between T1 and T3. A second limitation


























that needs to be addressed is the deﬁned timelines chosen for practical reasons i.e. when
patients had to come for their appointments (outpatient visit) to the Sleep Disordered
Breathing Clinic. Another caveat is, due to the prevalence of OSA, that the sample
reﬂects an imbalanced distribution representing the normal ratio between female and
male OSA patients. Not considering subjective sleepiness in the protocol can be other
limitation. Finally, although there is no precise key number for GEE analysis, it is rec-
ognized that the bigger the sample, the lower the amplitude of CI.
The present study shows important strengths, particularly the importance of theoreti-
cally derived constructs regarding adherence to APAP and the application of GEE’s sta-
tistical models, over time.
The results of this study guide prediction models related to adherence on OSA
patients. Further studies should focus on family variables like family coping and cogni-
tive representations regarding OSA, in APAP adherence, in periods over six months,
particularly in poorly adherent patients.
Conclusion and clinical implications
In conclusion, the results showed the importance of theoretically derived constructs in
predicting APAP adherence. In fact, APAP may provide better control of OSA increas-
ing patients’ outcome expectancies regarding APAP treatment. At the same time, with
APAP, patients may perceive themselves as self-efﬁcient in managing the disease taking
in to consideration family coping strategies that may function as cues to action feeding
self-efﬁcacy, as well and as a result, improving their quality of life.
Taking the results in to consideration, it is important for health professionals to
assess patients and differentiate adherence patterns, in order to individualize interven-
tions tailored to the patients’ adherence patterns. Interventions, during APAP treatment,
that take in to consideration the patient’s age and include a key family member like a
partner are crucial in promoting adherence to APAP. As a result, intervention in OSA
and particularly in APAP adherence should be focused on the family as the unit of
treatment.
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